673 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
LLY Eli Lilly and Company $105.71 $113.53B N/A
Article Searches
Novartis Tests New Alzheimer's Drugs on People Who Don't Have the Disease https://www.wsj.com/articles/novartis-tests-new-alzheimers-drug-on-people-who-dont-have-the-disease-1492871315?mod=pls_whats_news_us_business_f Apr 23, 2017 - Subjects at high risk of developing Alzheimer’s—but who don’t actually have the disease—are being recruited to help test two experimental treatments from Novartis AG, in a new focus on preventive treatment.
America's 12 Most Charitable Companies https://www.fool.com/investing/2017/04/25/americas-12-most-charitable-companies.aspx?source=iedfolrf0000001 Apr 25, 2017 - These healthcare, bank, and tech companies are leading the way in investing in global change.
7 Reasons Why Prescription Drug Prices Are Extremely Expensive https://www.fool.com/investing/2017/06/09/7-reasons-why-prescription-drug-prices-are-extreme.aspx?source=iedfolrf0000001 Jun 09, 2017 - There are myriad reasons going to the drugstore hurts the wallet.
Early movers: MCD, AAPL, MGI, BABA, GM, FB, UAL, WMT, LLY & more http://www.cnbc.com/2017/04/17/early-movers-mcd-aapl-mgi-baba-gm-fb-ual-wmt-lly-more.html Apr 17, 2017 - Names on the move ahead of the open.
Read This Before You Buy Biotech Stocks https://www.fool.com/investing/2017/04/23/read-this-before-you-buy-biotech-stocks.aspx?source=iedfolrf0000001 Apr 23, 2017 - Looking to buy biotech stocks? Here are 7 important things to know.
FDA Rejects Eli Lilly and Incyte Drug https://www.wsj.com/articles/fda-rejects-eli-lilly-and-incyte-rheumatoid-arthritis-drug-1492183825?mod=pls_whats_news_us_business_f Apr 14, 2017 - Eli Lilly and Incyte said the U.S. Food and Drug Administration didn’t approve their new drug application for a rheumatoid arthritis treatment that some analysts estimate could generate more than $2 billion in annual sales.
The 4 Best Dividend Stocks in Pharmaceuticals https://www.fool.com/investing/2017/04/18/the-4-best-dividend-stocks-in-pharmaceuticals.aspx?source=iedfolrf0000001 Apr 18, 2017 - Find out how these pharma stocks could boost your dividend growth portfolio’s performance.
Stocks making the biggest moves premarket: BA, ANTM, ADP, LLY, AVY, XRX, EA & more https://www.cnbc.com/2018/01/31/stocks-making-the-biggest-moves-premarket-ba-antm-adp-lly-avy-xrx-ea-more.html Jan 31, 2018 - Names on the move ahead of the open.
These 5 Drugs Could Be Worth $45 Billion -- and They're Not Even on the Market Yet https://www.fool.com/investing/2017/07/23/these-5-drugs-could-be-worth-45-billion-and-theyre.aspx?source=iedfolrf0000001 Jul 23, 2017 - Biogen, Johnson & Johnson, Lilly, AbbVie, and Celgene could have huge winners on their hands in the near future.
Stocks making the biggest moves premarket: LLY, AAPL, TSLA, AMZN & more https://www.cnbc.com/2019/01/07/stocks-making-the-biggest-moves-premarket-lly-aapl-tsla-amzn--more.html Jan 07, 2019 - Names on the move ahead of the open.

Pages: 123456...68

Page 1>